EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, RVMD: Revolution Medicines Inc

30 Jan 26 15:59
LAST:

96.89

CHANGE:
 1.25		OPEN:
97.95		HIGH:
99.49		ASK:
0.00		VOLUME:
1.28M
CHG(%):
1.27		PREV:
98.20		LOW:
96.63		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
30 Jan 2698.0199.4996.6396.952.09M
29 Jan 2697.00100.1896.7898.202.48M
28 Jan 2699.04100.3096.7297.333.13M
27 Jan 2698.14101.9397.7599.823.57M
26 Jan 2693.5099.5192.5097.7810.18M
23 Jan 26118.40120.63117.59117.632.52M
22 Jan 26118.36120.53116.55118.813.19M
21 Jan 26115.60118.43114.81117.533.88M
20 Jan 26118.59119.75113.96116.225.31M
16 Jan 26124.45124.49119.61120.284.8M

PROFILE

Name:Revolution Medicines Inc
About:Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
Sector:Healthcare
Industry:Biotechnology
Address:700 Saginaw Drive, Redwood City, CA, United States, 94063
Website:https://www.revmed.com
CUSIP:76155X100
CIK:0001628171
ISIN:US76155X1000
FIGI:BBG00829F4P8
LEI:549300JU3X0LBCQ65892

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-16.57 
Forward P/E:-16.34 
PEG Ratio:-0.27 
Price to Sales:9,035.10 
Price to Book:12.20 
Return on Assets:-0.26 
Return on Equity:-0.47 
EPS Ratio:-5.19 
Revenue:742.0K 
Shares:193.32M 
Market Cap:18.731B 

TECHNICAL INDICATORS

MA5:98.021.2%
MA10:108.0611.5%
MA20:106.409.8%
MA50:88.929.0%
MA100:70.3337.8%
MA200:54.4278.1%
RSI14:25.96 
WPR14:-100.00 
MTM14:-20.11
ROC14:-0.17 
ATR:5.57 
Week High:120.6324.5%
Week Low:92.504.7%
Month High:124.4928.5%
Month Low:76.2878.1%
Year High:124.4928.5%
Year Low:29.17232.2%